Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00395759 · ClinicalTrials.gov registry record · NA
The Visual Effect of an Investigational Artificial Tear in the Tear Layer.
A NA study of Dry Eye Disease, sponsored by Southern California College of Optometry at Marshall B. Ketchum University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT00395759: Completed NA study of Dry Eye Disease, sponsored by Southern California College of Optometry at Marshall B. Ketchum University.
NCT00395759 is a NA study of Dry Eye Disease that has completed, run by Southern California College of Optometry at Marshall B. Ketchum University. The registered enrollment target is 30 participants, below the 254-participant average among 33 other Dry Eye Disease trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00395759, a NA study of Dry Eye Disease, has completed, sponsored by Southern California College of Optometry at Marshall B. Ketchum University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate how the addition of a new artificial tear product when applied to the tear layer affects contrast sensitivity and optical aberrations over time. We will also determine if there are any adverse effects associated with drop instillation.
Conditions Studied
Interventions
- DRUG Optiva artificial tear by Allergan
Study Locations (1)
California
- Southern California College of Optometry - Fullerton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2005-09 |
| Est. Completion | 2007-09 |
| Phase | NA |
What the finished NCT00395759 record still lists
NCT00395759 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 254-participant average among 33 other Dry Eye Disease trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Dry Eye Disease appearing as the primary indexed condition, and to 1 intervention - of which Optiva artificial tear by Allergan is the first listed.
NCT00395759 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00395759 about?
NCT00395759 is a clinical study titled "The Visual Effect of an Investigational Artificial Tear in the Tear Layer.". The purpose of this study is to investigate how the addition of a new artificial tear product when applied to the tear layer affects contrast sensitivity and optical aberrations over time. We will also determine if there are any adverse effects associated with drop instillation.
What is the current status of trial NCT00395759?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2005-09. Estimated completion is 2007-09.
What conditions does trial NCT00395759 study?
This clinical trial studies the following conditions: Dry Eye Disease.
What interventions are being tested in trial NCT00395759?
The interventions under investigation include: Optiva artificial tear by Allergan (DRUG).
Who is sponsoring clinical trial NCT00395759?
This trial is sponsored by Southern California College of Optometry at Marshall B. Ketchum University, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00395759 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dry Eye Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00395759's enrollment target sits among peer trials
30 32nd of 33 higher than 1 of 33 other Dry Eye Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dry Eye Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD
ACTIVE NOT RECRUITING · NA
-
Evaluation of Ocular Comfort With ISTA Tears vs Systane
COMPLETED · NA
-
In Vivo Confocal Microscopic Analysis of Corneal Nerve Changes After ProKera Slim® for Dry Eye
COMPLETED · NA
-
A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult Participants With Dry Eye Disease
RECRUITING · Phase 3
-
A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory Treatment
RECRUITING · Phase 4
-
Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED).
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia